期刊文献+

外周血淋巴细胞HLA-B27表达强度与强直性脊柱炎临床分期的关系 被引量:5

Relationship between expression intensity of HLA-B27 in peripheral blood lymphocyte and clinical stage of ankylosing spondylitis
在线阅读 下载PDF
导出
摘要 目的了解强直性脊柱炎(AS)不同临床分期患者外周血淋巴细胞人类白细胞抗原B27(HLA-B27)表达量与疾病临床分期之间的关系。方法采用三色流式细胞学检测技术分析88例不同阶段AS患者及132例健康人的外周血淋巴细胞HLA-B27表达率及表达强度(MNX)。结果 AS进展期患者外周血淋巴细胞HLA-B27表达率的中位数、P25、P75分别是95.34%、86.60%、97.39%,MNX的中位数、P25、P75分别为8.70、5.20、10.80;强直期患者外周血淋巴细胞HLA-B27表达率的中位数、P25、P75分别是94.51%、90.40%、97.83%,MNX的中位数、P25、P75分别为8.40、6.05、15.95。健康对照组的外周血淋巴细胞HLA-B27表达率的中位数、P25、P75分别是3.69%、1.03%、11.13%,MNX的中位数、P25、P75分别为1.50、1.30、1.90。Mann-Whitney U检验显示,AS患者进展期与强直期的外周血淋巴细胞HLA-B27表达率及MNX均差异无统计学意义(P>0.05);进展期、强直期与健康对照组的外周血淋巴细胞HLA-B27表达率及MNX均差异有统计学意义(P<0.05)。结论外周血淋巴细胞HLA-B27的表达率及MNX适合于AS诊断,对AS病情判断无辅助意义。 Objective To study the relationship between the expression amount of peripheral blood lymphocyte HLA-B27 with the clinical stages in the patients with different clinical stages of ankylosing spondylitis(AS).Methods The expression rate and the expression intensity(MNX)of peripheral blood lymphocyte HLA-B27 were detected in 88 cases of different stages of AS and 132 healthy individuals by the three-color flow cytometry and the results were analyzed statistically.Results The median number,P25 and P75of peripheral blood lymphocyte HLAB27 expression rate in the patients with progressive stage of AS were 95.34%,86.60%and 97.39%respectively,the median number,P25 and P75of MNX were 8.70,5.20 and 10.80respectively;the median number,P25 and P75of peripheral blood lymphocyte HLA-B27 expression rate in the rigidity stage were 94.51%,90.40% and97.83%respectively,the median number,P25 and P75of MNXwere 8.40,6.05 and 15.95 respectively.The median number,P25,P75 of peripheral blood lymphocyte HLA-B27 expression rate in the healthy control group were3.69%,1.03%and 11.13%,respectively,the median number,P25 and P75of MNX were 1.50,1.30 and 1.90 respectively.The Mann-Whitney U test showed that the expression rate and MNX of peripheral blood lymphocyte HLA-B27 no statistically significant differences between the progressive stage and the rigidity stage in AS patients(P〉0.05);the differences in the expression rate and MNX of peripheral blood lymphocyte HLA-B27 among the progressive stage,rigidity stage and the healthy control group had statistical significance.Conclusion The expression rate and MNX of peripheral blood lymphocyte HLA-B27 are suitable for the diagnosis of AS and have no auxiliary significance in the judgment of AS condition.
出处 《检验医学与临床》 CAS 2014年第21期2971-2973,共3页 Laboratory Medicine and Clinic
关键词 强直性脊柱炎 临床分期 HLA-B27 蛋白质表达 流式细胞术 ankylosing spondylitis clinical stage HLA-B27 protin expressing flow cytometry
  • 相关文献

参考文献10

二级参考文献55

共引文献2918

同被引文献42

  • 1洪俊,张平安,李艳,饶永彩.强直性脊柱炎患者人类白细胞抗原B27三种检测方法的对比[J].检验医学,2006,21(1):1-4. 被引量:12
  • 2Hendren L,Beeson P.A review of the differences between normal and osteoar-thritis articular cartilage in human knee and ankle joints[J].The Foot,2009,19(3):171-176.
  • 3Dean LE, Jones GT, Mac Donald AG, et al. Global prevalence of ankylosing spondylitis[J], Rheumatolo- gy(Oxford) ,2014,53(4) : 650-657.
  • 4Sieper J, Braun J, Kay J, et al. Sarilumab .for the treat ment of ankylosing spondylitis:results of a Phase II, randomised, double-blind, placebo-c0ntrolled study (ALIGN)[J]. Ann Rheum Dis, 2015,74 (6): 1051 i057.
  • 5Robinsbn PC,Brown MA. The genetics of anky|osing spondylitis and axial spondyloarthritis [J]. Rheum Dis Clin North Am,2012,38(3):539-553.
  • 6Zhang L, Liu JL, Zhang YJ, et al. Association between HLA-B 27 polymorphisms and ankylosing spondyli- tis in Han populations: a meta-analysis[J]. Clin Exp Rheumatol, 2011,29(2) : 285-292.
  • 7Cauli A, Dessole G, Vacca A, et al. Susceptibility to ankylosing spondylitis but not disease outcome is in- fluenced by the level of HLA-B27 expression, which shows moderate variability over time[J]. Scandinavi- an Journal of Rheumatology,2012,41 (3) : 214-218.
  • 8Jiang YT, Yang MC, Wu HS, et al. The relationship between disease activity measured hy the BASDAI and psychological status, stressful life e,(ents, and sleep quality in ankylosing spondylitis [J]. Clinical Rheumatology, 2015,34 (3) : 503-510.
  • 9Pedersen SJ, Srensen IJ, Garnero P, et al. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFa inhibitors [J]. Annals of the Rheumatic Diseases,2011,70(8) : 1375-1381.
  • 10Bettencourt BF, Rocha FL, Alves H, et al. Protective effect of an ERAP1 haplotype in ankylosing spondy- IRis:investigating non-MHC genes in HLA-B27-pos- itive individuals[J]. Rheumatology(Oxford), 2013,52 (12) :2168-2176.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部